DigitalHealth.London Spotlight: Megi Health

February is Heart Month, a campaign by the British Heart Foundation that highlights the importance of learning CPR and monitoring heart health.

To mark the campaign, we shine the DigitalHealth.London spotlight on Accelerator and Accelerating FemTech company, MEGI Health. In this blog, they discuss how their powerful solution for hypertension care can support doctors to detect high blood pressure earlier, improving patient outcomes.

What is the problem you are trying to solve and why is it important?

In the UK, 8 million people have undiagnosed or uncontrolled high blood pressure, often feeling fine while their heart is under silent attack. This “invisible killer” is associated with 50% of heart attacks and strokes, striking without warning. Every day, 290 people in the UK are rushed to hospital with a heart attack. Some cases could have been prevented.

Healthcare costs related to heart and circulatory diseases are estimated at £12 billion per year in the UK, worsening hospital strain and lengthening waiting lists. Early detection, timely treatment, and continuous care are critical to reducing this burden. Every delayed diagnosis costs more than money—it costs lives.

What is the solution you have developed and how can it help with the problem?

Megi is a simple yet powerful solution for hypertension care, designed to screen, diagnose, and monitor patients more efficiently. Unlike complex health apps, Megi works where people already are, primarily on WhatsApp, allowing them to input medical and lifestyle data via text or camera. It ensures early detection of high blood pressure and provides continuous therapy monitoring to keep treatment aligned with each patient’s needs. Built for all ages and tech abilities, it feels natural to use daily.

By helping doctors detect hypertension earlier, guide them to therapy earlier, save time, improve patient outcomes, and streamline data collection, Megi reduces strain on the doctors, NHS while enhancing care.

What is the history of your company?

MEGI Health was developed within a specialised cardiovascular hospital, Magdalena Clinic where we saw firsthand the challenges of diagnosing and managing hypertension effectively. Doctors needed a solution that was simple for patients yet powerful enough to support clinical decisions, so MEGI was built to do exactly that.

From the start, it was in patients’ hands, ensuring it was easy to use and truly effective.
To encase the solution we then formed a strategic partnership with King’s College London, combining leading research with real-world clinical experience to create a smarter, more impactful hypertension solution. Today, MEGI has helped over 11,000 patients and doctors across Europe and Africa take control of their blood pressure and receive better care.

What successes have you had so far from successful pilots/trials/contracts?

MEGI users see an average blood pressure reduction of 10 mmHg, reducing their risk of heart attack and stroke by 20%. A simple intervention, a life-changing impact.

• We achieved a 63.1% retention rate for self-reported hypertensive users—an exceptional result considering that most mobile apps, including games, have a retention rate of less than 5% after one month.
• We have successfully managed hypertension for over 11,000 patients across the private and public sectors in Europe and Africa, demonstrating MEGI’s scalability and ability to transform care at population level.
• In a UK pilot with a GP Trust, 40.4% of screened patients were diagnosed with hypertension. Of those, 66.7% continued using MEGI for ongoing monitoring, ensuring they stayed engaged in their treatment and received the care they needed.

What are your future goals? What does success look like?

• Ensure every patient gets the right care at the right time
• Expand MEGI’s reach across the UK, integrating with hospitals and NHS services to provide earlier diagnosis, continuous monitoring, and personalized treatment for hypertension.
• Make hypertension management truly personal
• Enhance MEGI’s AI to offer even more tailored insights, adapting to each patient’s lifestyle, medication response, and daily health data, ensuring therapy stays aligned with their needs.
• Give doctors more time for real care
• Further streamline administrative work by automating blood pressure tracking, patient follow-ups, and treatment adjustments, allowing healthcare providers to focus on clinical decisions and patient relationships.

How has your time on the DigitalHealth.London Accelerator helped you in achieving these?

Our journey with DigitalHealth.London started with the Launchpad programme, which gave us a solid foundation, helping us understand the UK healthcare landscape, make our first connections, and grasp the complexities of the market. This was invaluable as we prepared to expand into the UK.

Joining the Accelerator programme then took our growth to the next level. It provided deep dives into key topics, expert guidance, mentorship, and access to different events. But most importantly, it connected us with an incredible network of peers, companies facing similar challenges, sharing insights, and learning from each other.

Our navigator played a crucial role, always available for even the smallest questions and actively supporting our expansion in every way possible.

Do you have any advice for aspiring digital health companies?

1. Understand the healthcare landscape
   The NHS is more complex than it seems. With MEGI Health, we quickly learned that understanding the processes, decision-making structures, and funding pathways is crucial, especially when entering the UK market. Without this, positioning your solution effectively is difficult.
   
2. Engage with end-users early
   You can have the best solution, but if patients and clinicians don’t use it, it won’t matter. Involving them from the start ensures real-world adoption and impact.
   
3. Prioritise compliance early
   Meeting regulatory standards is essential for any pilot or trial—and it takes time. Plan this from day one to avoid delays.
   
4. Build the right network
   Programmes like DigitalHealth.London provide access to mentors, experts, and peers who can open doors and help navigate challenges you didn’t expect. Connections matter.

Any asks for the audience?

Thousands live with undiagnosed high blood pressure, and the NHS spends billions on preventable complications. MEGI is changing this—but we need partners. If you’re a UK healthcare provider, clinician, patient or policymaker, let’s collaborate on pilots, research, and real impact. Contact Ines Knezevic at ines@megi.ai.

Learn more about Megi Health’s solution at this year’s Best Practice Conference. The company join Accelerating FemTech Senior Programme Manager, Katya Masconi-Yule, as well as Freeda AI and Bloomful to explore how digital innovations are supporting women’s experiences and outcomes across primary care.

Accelerating FemTech: how innovators are pushing forward women’s health in primary care is on Wednesday 26 February at 11:30am-12:00pm at Women’s Health Workshop Theatre, Olympia, London.

Women’s Health Professional Care is part of Best Practice London 2025. The conference runs from Wednesday 26 February to Thursday 27 February 2025 at Olympia, London. Find out more.

Megi Health is currently in Cohort 8 of the DigitalHealth.London Accelerator programme and is an alumnus of the DigitalHealth.London Leap programme.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England, the Mayor of London and the Levelling Up Fund.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.